SYNOPSYS INC (SYP.DE) Fundamental Analysis & Valuation

FRA:SYP • US8716071076

Current stock price

337 EUR
-7.5 (-2.18%)
Last:

This SYP.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SYP.DE Profitability Analysis

1.1 Basic Checks

  • SYP had positive earnings in the past year.
  • In the past year SYP had a positive cash flow from operations.
  • SYP had positive earnings in each of the past 5 years.
  • Each year in the past 5 years SYP had a positive operating cash flow.
SYP.DE Yearly Net Income VS EBIT VS OCF VS FCFSYP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B -15B

1.2 Ratios

  • SYP has a Return On Assets (2.33%) which is in line with its industry peers.
  • SYP has a Return On Equity (3.61%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.60%, SYP is in line with its industry, outperforming 50.82% of the companies in the same industry.
  • SYP had an Average Return On Invested Capital over the past 3 years of 7.77%. This is significantly below the industry average of 13.21%.
  • The last Return On Invested Capital (1.60%) for SYP is well below the 3 year average (7.77%), which needs to be investigated, but indicates that SYP had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.33%
ROE 3.61%
ROIC 1.6%
ROA(3y)10.66%
ROA(5y)10.22%
ROE(3y)16.63%
ROE(5y)16.41%
ROIC(3y)7.77%
ROIC(5y)8.83%
SYP.DE Yearly ROA, ROE, ROICSYP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 13.76%, SYP is in the better half of the industry, outperforming 69.67% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SYP has remained more or less at the same level.
  • SYP has a better Operating Margin (12.29%) than 63.93% of its industry peers.
  • In the last couple of years the Operating Margin of SYP has declined.
  • SYP has a Gross Margin of 75.14%. This is comparable to the rest of the industry: SYP outperforms 53.28% of its industry peers.
  • SYP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.29%
PM (TTM) 13.76%
GM 75.14%
OM growth 3Y-19.79%
OM growth 5Y-5.43%
PM growth 3Y-3.98%
PM growth 5Y0.93%
GM growth 3Y-1.5%
GM growth 5Y-0.37%
SYP.DE Yearly Profit, Operating, Gross MarginsSYP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

3

2. SYP.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SYP is destroying value.
  • Compared to 1 year ago, SYP has more shares outstanding
  • Compared to 5 years ago, SYP has more shares outstanding
  • SYP has a worse debt/assets ratio than last year.
SYP.DE Yearly Shares OutstandingSYP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
SYP.DE Yearly Total Debt VS Total AssetsSYP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 3.30 indicates that SYP is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.30, SYP is doing good in the industry, outperforming 62.30% of the companies in the same industry.
  • SYP has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
  • SYP has a Debt to Equity ratio of 0.33. This is comparable to the rest of the industry: SYP outperforms 45.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 3.3
ROIC/WACC0.16
WACC10.25%
SYP.DE Yearly LT Debt VS Equity VS FCFSYP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B

2.3 Liquidity

  • SYP has a Current Ratio of 1.36. This is a normal value and indicates that SYP is financially healthy and should not expect problems in meeting its short term obligations.
  • SYP has a Current ratio of 1.36. This is comparable to the rest of the industry: SYP outperforms 46.72% of its industry peers.
  • SYP has a Quick Ratio of 1.26. This is a normal value and indicates that SYP is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of SYP (1.26) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.26
SYP.DE Yearly Current Assets VS Current LiabilitesSYP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

6

3. SYP.DE Growth Analysis

3.1 Past

  • SYP shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.77%.
  • The Earnings Per Share has been growing by 18.54% on average over the past years. This is quite good.
  • Looking at the last year, SYP shows a very strong growth in Revenue. The Revenue has grown by 31.88%.
  • Measured over the past years, SYP shows a quite strong growth in Revenue. The Revenue has been growing by 13.87% on average per year.
EPS 1Y (TTM)6.77%
EPS 3Y13.39%
EPS 5Y18.54%
EPS Q2Q%24.42%
Revenue 1Y (TTM)31.88%
Revenue growth 3Y15.19%
Revenue growth 5Y13.87%
Sales Q2Q%65.52%

3.2 Future

  • Based on estimates for the next years, SYP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.44% on average per year.
  • SYP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.92% yearly.
EPS Next Y13.53%
EPS Next 2Y15.89%
EPS Next 3Y17%
EPS Next 5Y14.44%
Revenue Next Year36.66%
Revenue Next 2Y23.02%
Revenue Next 3Y18.89%
Revenue Next 5Y14.92%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SYP.DE Yearly Revenue VS EstimatesSYP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
SYP.DE Yearly EPS VS EstimatesSYP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

2

4. SYP.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 28.75, the valuation of SYP can be described as expensive.
  • SYP's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of SYP to the average of the S&P500 Index (26.86), we can say SYP is valued inline with the index average.
  • Based on the Price/Forward Earnings ratio of 22.62, the valuation of SYP can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SYP is on the same level as its industry peers.
  • SYP's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.39.
Industry RankSector Rank
PE 28.75
Fwd PE 22.62
SYP.DE Price Earnings VS Forward Price EarningsSYP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • SYP's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 40.71
SYP.DE Per share dataSYP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SYP does not grow enough to justify the current Price/Earnings ratio.
  • SYP's earnings are expected to grow with 17.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.13
PEG (5Y)1.55
EPS Next 2Y15.89%
EPS Next 3Y17%

0

5. SYP.DE Dividend Analysis

5.1 Amount

  • No dividends for SYP!.
Industry RankSector Rank
Dividend Yield 0%

SYP.DE Fundamentals: All Metrics, Ratios and Statistics

SYNOPSYS INC

FRA:SYP (4/10/2026, 7:00:00 PM)

337

-7.5 (-2.18%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-25
Earnings (Next)05-26
Inst Owners91.1%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap64.56B
Revenue(TTM)8.01B
Net Income(TTM)1.10B
Analysts80
Price Target470.25 (39.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.14%
Min EPS beat(2)2.36%
Max EPS beat(2)3.92%
EPS beat(4)3
Avg EPS beat(4)0.41%
Min EPS beat(4)-10.9%
Max EPS beat(4)6.25%
EPS beat(8)6
Avg EPS beat(8)1.17%
EPS beat(12)9
Avg EPS beat(12)1.05%
EPS beat(16)13
Avg EPS beat(16)1.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.41%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)-1.2%
Revenue beat(8)0
Avg Revenue beat(8)-2.19%
Revenue beat(12)0
Avg Revenue beat(12)-1.93%
Revenue beat(16)0
Avg Revenue beat(16)-4.49%
PT rev (1m)-2.08%
PT rev (3m)-3.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.1%
EPS NY rev (1m)0.12%
EPS NY rev (3m)0.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE 28.75
Fwd PE 22.62
P/S 9.44
P/FCF N/A
P/OCF 30.95
P/B 2.47
P/tB N/A
EV/EBITDA 40.71
EPS(TTM)11.72
EY3.48%
EPS(NY)14.9
Fwd EY4.42%
FCF(TTM)-64.2
FCFYN/A
OCF(TTM)10.89
OCFY3.23%
SpS35.69
BVpS136.17
TBVpS-38.43
PEG (NY)2.13
PEG (5Y)1.55
Graham Number189.5
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 3.61%
ROCE 2.27%
ROIC 1.6%
ROICexc 1.69%
ROICexgc 36.07%
OM 12.29%
PM (TTM) 13.76%
GM 75.14%
FCFM N/A
ROA(3y)10.66%
ROA(5y)10.22%
ROE(3y)16.63%
ROE(5y)16.41%
ROIC(3y)7.77%
ROIC(5y)8.83%
ROICexc(3y)10.92%
ROICexc(5y)12.04%
ROICexgc(3y)46.31%
ROICexgc(5y)58.99%
ROCE(3y)11.04%
ROCE(5y)12.54%
ROICexgc growth 3Y-30.11%
ROICexgc growth 5Y-5.25%
ROICexc growth 3Y-54.14%
ROICexc growth 5Y-30.5%
OM growth 3Y-19.79%
OM growth 5Y-5.43%
PM growth 3Y-3.98%
PM growth 5Y0.93%
GM growth 3Y-1.5%
GM growth 5Y-0.37%
F-Score3
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 4.89
Cap/Depr 1584.42%
Cap/Sales 210.37%
Interest Coverage 250
Cash Conversion 119.31%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.26
Altman-Z 3.3
F-Score3
WACC10.25%
ROIC/WACC0.16
Cap/Depr(3y)948.17%
Cap/Depr(5y)656.53%
Cap/Sales(3y)84.22%
Cap/Sales(5y)54.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.77%
EPS 3Y13.39%
EPS 5Y18.54%
EPS Q2Q%24.42%
EPS Next Y13.53%
EPS Next 2Y15.89%
EPS Next 3Y17%
EPS Next 5Y14.44%
Revenue 1Y (TTM)31.88%
Revenue growth 3Y15.19%
Revenue growth 5Y13.87%
Sales Q2Q%65.52%
Revenue Next Year36.66%
Revenue Next 2Y23.02%
Revenue Next 3Y18.89%
Revenue Next 5Y14.92%
EBIT growth 1Y-21.56%
EBIT growth 3Y-7.6%
EBIT growth 5Y7.68%
EBIT Next Year50.21%
EBIT Next 3Y25.04%
EBIT Next 5Y15.51%
FCF growth 1Y-1620.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.78%
OCF growth 3Y-4.41%
OCF growth 5Y8.9%

SYNOPSYS INC / SYP.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SYNOPSYS INC (SYP.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SYP.DE.


What is the valuation status for SYP stock?

ChartMill assigns a valuation rating of 2 / 10 to SYNOPSYS INC (SYP.DE). This can be considered as Overvalued.


Can you provide the profitability details for SYNOPSYS INC?

SYNOPSYS INC (SYP.DE) has a profitability rating of 5 / 10.


What is the expected EPS growth for SYNOPSYS INC (SYP.DE) stock?

The Earnings per Share (EPS) of SYNOPSYS INC (SYP.DE) is expected to grow by 13.53% in the next year.